High-throughput SOLiDTM sequencing technology was applied to analyse genome-wide profiles of miRNAs in the tumour and serum of LLC-bearing mice after multiple i.m. administration of RNase A at the dose provided for antitumour and antimetastatic effects [24]. Here, RNASE1 is linked to neoplasm.